Risk factor
Very poor trading liquidity
Profitability factor
Favourable analyst view
About
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E.
Target Price
The average target price of 7774.T is 1200 and suggests 82% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell